A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Public ClinicalTrials.gov record NCT02660424. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomized, Double-blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Primary objective of this study is to evaluate the efficacy of VX-150 in the treatment of osteoarthritis pain
Study identification
- NCT ID
- NCT02660424
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2015
- Primary completion
- Jul 31, 2016
- Completion
- Aug 31, 2016
- Last update posted
- Sep 29, 2020
2015 – 2016
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | San Diego | California | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Valparaiso | Indiana | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Bay City | Michigan | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Hartsdale | New York | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Providence | Rhode Island | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Danville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02660424, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02660424 live on ClinicalTrials.gov.